Corrigendum to “Role of Baicalin in Anti-Influenza Virus A as a Potent Inducer of IFN-Gamma”

---

In the article titled “Role of Baicalin in Anti-Influenza Virus A as a Potent Inducer of IFN-Gamma” [1], there appears to be an image duplication in Figure 1, as raised on PubPeer [2]. In Figure 1(c), the panel showing the 100x + untreated mice inadvertently duplicated the panel showing the 100x + 2.0 g/kg BA-treated mice.

(a)

(b)

(c)

Figure 1 

Antiviral activity of BA in treating A/PR/8/34-infected mice. Mice were inoculated with virus intranasally and treated with BA at the indicated concentration every 24 h for 14 days. Each group consists of 10 mice. (a) Survival rate of mice was observed in the next two weeks. ▲: untreated mice; ●: control A/PR/8/34-infected mice; ∆: 1.0 g/kg BA-treated mice; ○: 1.5 g/kg BA-treated mice; □: 2.0 g/kg BA-treated mice. (b) Lungs of mice were homogenized separately, diluted, and centrifuged on the third, fifth, and seventh day after infection, and the EID₅₀s were determined using 10-day chick embryo. (c) Lungs of mice were removed and examined pathologically using HE staining on the seventh day after infection. ^#Levels of significance of against untreated mice; against control infected mice; against control infected mice.

The corrected figure, as approved by the editorial board, is shown below.